SEC Filing Summary: Prestige Consumer Healthcare Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed on May 9, 2019, by Prestige Consumer Healthcare Inc. The filing primarily serves to announce financial results for the fiscal quarter and fiscal year ended March 31, 2019, and to disclose a new share repurchase program authorized by the Board of Directors.
Key Financial Metrics
The filing text references the announcement of financial results for the quarter and year ended March 31, 2019, but does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the body of this report. These figures are contained in the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are incorporated by reference.
Material Changes and Corporate Actions
- Share Repurchase Program: The Board of Directors authorized a program to repurchase up to $50.0 million of the Company's issued and outstanding common stock.
- Program Duration: The repurchase program is effective through May 2020.
- Execution Method: Repurchases may be conducted via open market transactions, through investment banking institutions, or via privately negotiated transactions.
- Timing: The timing and amount of repurchases will depend on market and business conditions, legal requirements, and other corporate considerations.
Guidance, Outlook, and Risks
The Company began investor presentations on May 9, 2019, utilizing an Investor Presentation (Exhibit 99.2) intended for use throughout the fiscal year ended March 31, 2020. The filing includes standard disclaimers stating that the Company undertakes no duty or obligation to publicly update or revise the information contained in the report or the investor presentation, although it may do so as management deems warranted. No specific forward-looking guidance or risk factors are detailed in the text of this 8-K summary.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and earnings per share figures for the quarter and year ended March 31, 2019.
- Examine Exhibit 99.2 (Investor Presentation) for management's outlook, strategic initiatives, and detailed financial metrics.
- Monitor future filings or press releases for updates on the execution of the $50.0 million share repurchase program.
- Verify the Company's liquidity position and debt levels in the full quarterly report (Form 10-Q) corresponding to the period ended March 31, 2019.